SPARK for Children With Cancer

Overseen By Dr. Lillian Sung

Age: < 65

Sex: Any

Trial Phase: Academic

Sponsor: The Hospital for Sick Children

Disqualifiers: Cognitive disability, Visual impairment

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

30 Participants Needed

Trial Summary

What is the purpose of this trial?

This study will evaluate the feasibility of three times weekly symptom reporting by children using the SPARK platform for 8 weeks. SPARK is a web-based application that promotes symptom screening for children receiving cancer therapies and enables access to clinical practice guidelines for symptom management. Newly diagnosed and relapsed patients with cancer will be enrolled. Children and/or their guardian will be prompted to complete symptom screening three times weekly via SPARK with corresponding feedback sent to their healthcare providers with each completed assessment. Symptom reports will contain links to clinical practice guidelines for symptom management. Active intervention will last for 8 weeks starting from the date of enrollment.

Research Team

Lillian Sung, MD, PhD

Principal Investigator

The Hospital for Sick Children

Eligibility Criteria

This trial is for children aged 8-18 with a cancer diagnosis who are undergoing or planning to undergo chemotherapy, radiotherapy, or surgery. Participants must understand English or Spanish and will use the SPARK platform to report symptoms three times weekly.

Inclusion Criteria

My child is scheduled for or has had cancer treatment.

I have been diagnosed with cancer.

I understand English or Spanish.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Symptom Screening

Three times weekly symptom reporting by children using the SPARK platform

8 weeks

Symptom reporting three times weekly via SPARK

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

• SPARK

Trial Overview The study tests the SPARK platform's feasibility for symptom reporting by children with cancer. Over eight weeks, participants will regularly input their symptoms into SPARK, which then informs healthcare providers and offers guidelines for managing these symptoms.

Participant Groups

Group I: Three times weekly symptom screening Experimental Treatment 1 Intervention

Three times weekly symptom reporting by guardians and children using the SPARK platform for 8 weeks

Who Is Running the Clinical Trial?

The Hospital for Sick Children

Lead Sponsor

Trials

724

Recruited

6,969,000+